| 12083227 |
Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis |
Yuchuan Gong, Alexander Ruggles, Jared A. Baird, Hui Zu, Gregory A. McClelland +1 more |
2024-09-10 |
| 9107830 |
Inhibitors of crystallization in a solid dispersion |
James J. Fort, Steven L. Krill, Devalina Law, Eric A. Schmitt |
2015-08-18 |
| 8541026 |
Sustained release formulations of opioid and nonopioid analgesics |
Cheri E. Klein |
2013-09-24 |
| 8062664 |
Process for preparing formulations of lipid-regulating drugs |
Jacqueline Wardrop |
2011-11-22 |
| 7364752 |
Solid dispersion pharamaceutical formulations |
James J. Fort, Steven L. Krill, Devalina Law, William Porter, Eric A. Schmitt |
2008-04-29 |
| 6720004 |
Controlled release formulation of divalproex sodium |
J. Daniel Bollinger, Sandeep Dutta, Howard Cheskin, Kevin R. Engh, Richard P. Poska |
2004-04-13 |
| 6713086 |
Controlled release formulation of divalproex sodium |
J. Daniel Bollinger, Howard Cheskin, Sandeep Dutta, Kevin R. Engh, Richard P. Poska |
2004-03-30 |
| 6528090 |
Controlled release formulation of divalproex sodium |
J. Daniel Bollinger, Howard Cheskin, Sandeep Dutta, Kevin R. Engh, Richard P. Poska |
2003-03-04 |
| 6528091 |
Controlled release formulation of divalproex sodium |
Paul Richard Poska, Howard Cheskin, J. Daniel Bollinger, Robert K. Engh |
2003-03-04 |
| 6511678 |
Controlled release formulation of divalproex sodium |
J. Daniel Bollinger, Sandeep Dutta, Howard Cheskin, Kevin R. Engh, Richard P. Poska |
2003-01-28 |
| 6419953 |
Controlled release formulation of divalproex sodium |
Paul Richard Poska, Howard Cheskin, J. Daniel Bollinger, Robert K. Engh |
2002-07-16 |
| 6383517 |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption |
Venkatramana M. Rao, Kevin R. Engh, Thomas L. Reiland |
2002-05-07 |
| 6368622 |
Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
Yisheng Chen, Kevin R. Engh, Thomas L. Reiland |
2002-04-09 |
| 6180138 |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption |
Kevin R. Engh, Thomas L. Reiland |
2001-01-30 |
| 6150410 |
pH independent extended release pharmaceutical formulation |
Kevin R. Engh, Venkatramana M. Rao |
2000-11-21 |
| 6033685 |
Tablet for the controlled release of active agents |
Jay Trivedi, Sharon L. Graham, Kolette M. Flood, Steven L. Krill |
2000-03-07 |
